Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin

Published:2014-06-07 Issue:9 Volume:57 Page:1869-1875
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Zimdahl Heike,Ittrich Carina,Graefe-Mody Ulrike,Boehm Bernhard O.,Mark Michael,Woerle Hans-Juergen,Dugi Klaus A.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/article/10.1007/s00125-014-3276-y/fulltext.html

Reference28 articles.

1. International Diabetes Federation (2011) IDF diabetes atlas. Available from www.idf.org/diabetesatlas , accessed 4 September 2012

2. Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105–116

3. Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657–662

4. Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589

5. Cauchi S, El Achhab Y, Choquet H et al (2007) TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med (Berl) 85:777–782

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers and Precision Medicine in Diabetes;Textbook of Diabetes;2024-01-12

2. Pharmacogenomics: The roles of genetic factors on treatment response and outcomes in diabetes;Internet of Things and Machine Learning for Type I and Type II Diabetes;2024

3. Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations;Diabetes, Metabolic Syndrome and Obesity;2023-11

4. Pharmakogenetik neuer Glukosespiegelsenker: eine Chance für die Präzisionsmedizin?;Die Diabetologie;2023-01-24

5. Immunotropic effects of hypoglycemic agents on coronavirus infection: a view from the perspective of pharmacogenetics;Reviews on Clinical Pharmacology and Drug Therapy;2022-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3